Seronegative myasthenia gravis with bladder dysfunction

Rev Neurol (Paris). 2012 Mar;168(3):299-300. doi: 10.1016/j.neurol.2011.07.017. Epub 2012 Feb 23.

Authors

I Marouani, I Kraoua, H Benrhouma, I Rebai, A Rouissi, S Koubaa, I Turki, C Dziri, N Gouider-Khouja

PMID: 22365108
DOI: 10.1016/j.neurol.2011.07.017

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Action Potentials / physiology
Adolescent
Blepharoptosis / etiology
Cholinesterase Inhibitors / administration & dosage
Cholinesterase Inhibitors / therapeutic use
Electromyography
Female
Humans
Myasthenia Gravis / complications*
Myasthenia Gravis / immunology
Oculomotor Muscles / physiology
Pyridostigmine Bromide / administration & dosage
Pyridostigmine Bromide / therapeutic use
Thymectomy
Urinary Bladder, Neurogenic / drug therapy
Urinary Bladder, Neurogenic / etiology*
Urinary Bladder, Neurogenic / immunology
Urodynamics / drug effects
Urodynamics / physiology

Substances

Cholinesterase Inhibitors
Pyridostigmine Bromide